Iterum Therapeutics
ITRM
ITRM
22 hedge funds and large institutions have $31.6M invested in Iterum Therapeutics in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 2 increasing their positions, 7 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
25% less capital invested
Capital invested by funds: $42.3M → $31.6M (-$10.7M)
71% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 7
Holders
22
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$33K | |
| 2 | +$7.85K | |
| 3 | +$3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$1K |
Top Sellers
| 1 | -$129K | |
| 2 | -$80.5K | |
| 3 | -$54.9K | |
| 4 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$22.1K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
-$13.4K |